Molecular screening for RET proto-oncogene mutations in a German MEN2A pedigree

Endocrine Pathology

Volumn 7, Issue 1, 1996, Pages 71-76

  Wundrack, Iris ^a   Reichert, Jeannette ^a   Langer, Heinz Joachimy ^b   Leicht, Ernst ^b   Herrmann, Marille ^c   Subke, Frank ^b   Meese, Eckart ^b   Blin, Nikolaus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

C cell carcinoma; DNA mutation; Multiple endocrine neoplasia type 2A (MEN2A); RET oncogene

Indexed keywords

EID: 1842573996     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02739917     Document Type: Article

References (19)

1. Mathew C, Easton D, Nakamura Y, Ponder B, the MEN2A International Collaborative Group. Presymptomatic screening for MEN2A with linked DNA markers. Lancet 337:7-11, 1991.
2. Simpson N, Cann H. Report of the committee on the genetic constitution of chromosome 10. Cytogenet Cell Genet 58:428-458, 1991.
3. Howe J, Lairmore T, Mishra S, Dou S, Veile R, Wells S, Donis-Keller H. Improved predictive test for MEN2A, using flanking dinucleotide repeats and RFLPs. Am J Hum Genet 51:1430-1442, 1992.
4. McDonald H, Smailus D, Jenkins H, Adams K, Simpson N, Goodfellow P. Identification and characterization of a gene at D10S94 in the MEN2A region. Genomics 13:344-348, 1992.
5. Donis-Keller H, Dou S, Chi D, Carlson K, Toshima K, Lairmore T, Howe J, Moley J, Goodfellow P, Wells S. Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 2:851-856, 1993.
6. Mulligan L, Kwok J, Healey C, Eisdon M, Eng C, Gardner E, Love D, Mole S, Moore J, Papi L, Ponder M, Telenius H, Tunacliffe A, Ponder B. Germline mutations of the RET proto-oncogene in MEN2A. Nature 363:458-460, 1993.
7. Kwok J, Gardner E, Warner J, Ponder B, Mulligan L. Structural analysis of the human RET proto-oncogene using exon trapping. Oncogene 8:2575-2582, 1993.
8. Mulligan L, Eng C, Healey C, Clayton D, Kwok J, Gardner E, Ponder M, Frilling A, Jackson C, Lehnen H, Neumann H, Thibodeau S, Ponder B. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN2A and FMTC. Nature Genet 6:70-74, 1994.
9. Takiguchi-Shirahama S, Koyama K, Miyauchi A, Wakasugi T, Oishi S, Takami H, Hikiji K, Nakamura Y. Germline mutations of the RET proto-oncogene in eight Japanese patients with MEN2A. Hum Genet 95:187-190, 1995.
10. Mullenbach R, Lagoda P, Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet 5:391, 1989.
11. Feldman G, Kambouris M, Talpos G, Mulligan L, Ponder B, Jackson C. Clinical value of direct DNA analysis of the RET proto-oncogene in families with MEN2A. Surgery 116:1042-1047, 1994.
12. Schuchardt A, D'Agati V, Larson-Blomberg L, Constantini F, Pachnis A. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor RET. Nature 367:380-383, 1994.
13. Edery P, Lyonnet S, Mulligan L, Pelet A, Dow E, Abel L, Holder S, Nihoul-Fekete C, Ponder B, Munnich A. Mutations in the RET proto-oncogene in Hirschsprung's disease. Nature 367:378-380, 1994.
14. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M, Kaarlainen H, Martucciello G. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367:377, 378, 1994.
15. Carlson K, Dou S, Chi D, Scavarda N, Toshima K, Jackson C, Wells S, Goodfellow P, Donis-Keller H. Single missense mutation in the tyrosine kinase catalytic domain of the RET proto-oncogene is associated with MEN2B. Proc Natl Acad Sci USA 91:1579-1583, 1994.
16. Hofstra R, Landsvater R, Ceccherini I, Stulp R, Stelwagen T, Luo Y, Pasini B, Hoppner J, Amstel H, Romeo G, Lips C, Buys C. A mutation in the RET proto-oncogene associated with MEN2B and sporadic MTC. Nature 367:375,376, 1994.
17. Schuffenecker I, Billaud M, Calender A, Chambe B, Ginet N, Calmettes C, Modigliani E, Lenoir G. RET proto-oncogene mutations in French MEN2A and FMTC families. Hum Mol Genet 3:1939-1943, 1994.
18. Raue F, Frank-Raue K, Grauer A. Multiple endocrine neoplasia type 2: clinical features and screening. Endocrinol Metabol Clin N Am 23:137-156, 1994.
19. Snow KJ, Boyd AE. Management of individual tumor syndromes. Endocrinol Metabol Clin N Am 23:157-166, 1994.